Abstract:Porcine mucosal heparin was partially depolymerized with heparin lyase I and then fractionated into low-molecular-weight (< 5000) and high-molecular-weight (> 5000) oligosaccharides by pressure filtration. The high-molecular-weight oligosaccharide mixture (approximately 50 wt% of the starting heparin) also contained intact heparin. This intact polymer complicates oligosaccharide purification. Thus, the low-molecular-weight fraction was used to prepare homogeneous oligosaccharides for structural characterization. The low-molecular-weight oligosaccharide mixture was first fractionated by low-pressure gel permeation chromatography into size-uniform mixtures of disaccharides, tetrasaccharides, hexasaccharides, octasaccharides, decasaccharides, dodecasaccharides, tetradecasaccharides and higher oligosaccharides. Each size-fractionated mixture was then purified on the basis of charge by repetitive semi-preparative strong-anion-exchange high-performance liquid chromatography. This approach has led to the isolation of 14 homogeneous oligosaccharides from disaccharide to tetradecasaccharide. The purity of these heparin-derived oligosaccharides was determined by gradient polyacrylamide gel electrophoresis, analytical strong-anion-exchange high-performance liquid chromatography, capillary electrophoresis and one-dimensional nuclear resonance spectroscopy. The structure of these oligosaccharides was established using 600 MHz two-dimensional nuclear resonance spectroscopy. The spectral methods used included homonuclear correlation spectroscopy, nuclear Overhauser effect spectroscopy and heteronuclear multiple quantum coherence spectroscopy. The 1H/1H connectivities of the protons of each sugar residue in an oligosaccharide were established by two-dimensional homonuclear correlation spectroscopy, while 1H/13C assignments were made using 1H inverse detection. One- and two-dimensional nuclear resonance spectroscopic analysis of these heparin oligosaccharides showed two closely related groups of heparin-oligosaccharides are afforded by enzymatic depolymerization of heparin. One group is fully sulphated, having the structures delta UAp2S(1[-->4)-alpha-D-GlcNpS6S(1-->4)-alpha-L-IdoAp2S( 1]n-->4)-alpha- D-GlcNpS6S, where delta UAp is 4-deoxy-alpha-L-threo-hex-4-eno-pyranosyluronic acid, GlcNp is 2-deoxy-2-aminoglucopyranose, IdoAp is idopyranosyluronic acid, S is sulphate and n = 0-6. The other group of oligosaccharides differ in that they contain beta-D-glucuronic acid in place of the alpha-L-iduronic acid residue nearest to the reducing end. The present study describes the isolation and structural elucidation of seven new oligosaccharides: an octasaccharide, two decasaccharides, two dodecasaccharides and two tetradecasaccharides. The utility of two-dimensional nuclear resonance spectroscopy to determine the structure of complex heparin oligosaccharides is also illustrated.

Identification of a hexasaccharide sequence able to inhibit thrombin and suitable for 'polymerisation'

Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibition

Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A/ORG 31540)

Experimental proof for the structure of a thrombin-inhibiting heparin molecule

Preparation and structural characterization of large heparin-derived oligosaccharides

First steps in the direction of synthetic, allosteric, direct inhibitors of thrombin and factor Xa.

Synthesis of the Key Saccharide Fragments of the Glucuronic Acid-Containing Repeat Unit of Pentosan Polysulfate, a Heparin Sulfate Mimetic

Heparinase 1 Selectivity For The 3,6-Di-O-Sulfo-2-Deoxy-2-Sulfamido-Alpha-D-Glucopyranose (1,4) 2-O-Sulfo-Alpha-L-Idopyranosyluronic Acid (Glcns3s6s-Idoa2s) Linkages

Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido- -D-glucopyranose (1,4) 2-O-sulfo- -L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages

Sulfonate Groups and Saccharides As Essential Structural Elements in Heparin-Mimicking Polymers Used As Surface Modifiers: Optimization of Relative Contents for Antithrombogenic Properties.

Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia

Structural Analysis of Heparin-Derived 3-O-sulfated Tetrasaccharides: Antithrombin Binding Site Variants.

Synthesis of 3-O-sulfated Oligosaccharides to Understand the Relationship Between Structures and Functions of Heparan Sulfate.

Probing cleavage promiscuity of heparinase III towards chemoenzymatically synthetic heparan sulfate oligosaccharides.

Discovery of Heparin Mimetic, Potent, and Selective Inhibitors of Human Clotting Factor XIIIa

Identification of a heparosan heptasaccharide as an effective anti-inflammatory agent by partial desulfation of low molecular weight heparin

Structure-activity relationship of antithrombotic polysaccharide derivatives

Synthesis and Biological Profiling of Seven Heparin and Heparan Sulphate Analogue Trisaccharides

Sequencing the Oligosaccharide Pool in the Low Molecular Weight Heparin Dalteparin with Offline HPLC and ESI–MS/MS

Synthetic Oligosaccharides Can Replace Animal-Sourced Low–molecular Weight Heparins

Enzymatic access to the rare ΔUA (1→4) Glc 3, 6, N-sulfated heparin disaccharide, implications for heparin quality control